Slide 1
WE ARE EARLY PHASE
Slide 1
Slide 2
TRIAL EXPERTISE
Slide 2
Slide 3
THERAPEUTIC EXPERTISE
Slide 3
previous arrowprevious arrow
next arrownext arrow

We are EARLY Phase

We do one thing only, and we do it reliably in all shapes and colours – even yours.

FIND OUT WHO WE ARE

Trial Expertise

We deliver reliable research on everything first-in-human. And we do it in every relevant field and in our own clinical facilities.

LEARN ABOUT OUR METHODOLOGIES 

Therapeutic EXPERTISE

Our specialised units in 4 locations handle indications that range from cardiovascular to respiratory.

SEE OUR EXPERTISE BY INDICATION 

News

More News

Publications

Investigative Radiology
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults
Pharmacology Research & Perspectives
Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects
Cardiovasc Diabetology
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Metabolism Clinical and Experimental
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.
Journal of Clinical Pharmacology
(Bersacapavir) In Participants With Moderate Hepatic Impairment.
ESC Heart Failure Journal
Discordance between estimated and measured changes in plasma volume among patients with acute heart failure.
More Publications

Studies in cooperation with:

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board

LET’S TALK SCIENCE
Martin Mulder

Senior Vice President Corporate & Business Development

LET’S TALK BUSINESS
CRO Leadership Awards 2019

CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.

European Biotechnology Guide

Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.

EcoVadis – CSR Rating

Based on the CSR rating by EcoVadis in 2022 CRS has been granted Silver Recognition Level.